Company Filing History:
2 out of 1,216 
2 out of 518 
Years Active: 2018-2020
Title: Jaekyoung Son: Innovator in Cancer Treatment
Introduction
Jaekyoung Son is a prominent inventor based in Somerville, MA, specializing in innovative methods for cancer treatment. He has made significant contributions to the field, particularly in targeting metabolic pathways associated with oncogenic cancers. With a total of 2 patents, his work is paving the way for new therapeutic strategies.
Latest Patents
Jaekyoung Son's latest patents focus on the glutamine to pyruvate pathway for the treatment of oncogenic Kras-associated cancer. His patents include methods and kits for GPP-targeting, which are designed for the treatment of these specific cancers. Additionally, he has developed methods for determining the efficacy of these treatments, showcasing his commitment to advancing cancer therapy.
Career Highlights
Throughout his career, Jaekyoung Son has worked with esteemed institutions such as Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. His experience in these leading research centers has allowed him to collaborate with top professionals in the field, enhancing his research and innovation capabilities.
Collaborations
Some of Jaekyoung Son's notable coworkers include Alec C. Kimmelman and Lewis C. Cantley. Their collaborative efforts have contributed to the advancement of cancer research and treatment methodologies.
Conclusion
Jaekyoung Son's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His patents and collaborations reflect a dedication to improving patient outcomes in the fight against cancer.